MDPI and ACS Style

Luangdilok, S.; Wanchaijiraboon, P.; Pakvisal, N.; Susiriwatananont, T.; Zungsontiporn, N.; Sriuranpong, V.; Sainamthip, P.; Suntronwong, N.; Vichaiwattana, P.; Wanlapakorn, N.; Poovorawan, Y.; Teeyapun, N.; Tanasanvimon, S. Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine. Vaccines 2022, 10, 1613. https://doi.org/10.3390/vaccines10101613

Luangdilok S, Wanchaijiraboon P, Pakvisal N, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Sainamthip P, Suntronwong N, Vichaiwattana P, Wanlapakorn N, Poovorawan Y, Teeyapun N, Tanasanvimon S. Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine. Vaccines. 2022; 10(10):1613. https://doi.org/10.3390/vaccines10101613

Luangdilok, Sutima, Passakorn Wanchaijiraboon, Nussara Pakvisal, Thiti Susiriwatananont, Nicha Zungsontiporn, Virote Sriuranpong, Panot Sainamthip, Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Nattaya Teeyapun, and Suebpong Tanasanvimon. 2022. "Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine" Vaccines 10, no. 10: 1613. https://doi.org/10.3390/vaccines10101613